Less Invasive Screening for Colorectal Cancer by Microbiota Analysis: Is it a Reality or an Illusion?

Affiliations

Comment

Hisashi Onodera. EBioMedicine. 2017 Nov.

. 2017 Nov:25:5-6.

doi: 10.1016/j.ebiom.2017.10.020. Epub 2017 Oct 19.

¹ St. Luke's International University, Tokyo 104-8560, Japan. Electronic address: onohisa@luke.ac.jp.

No abstract available

Comment on

Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
Xie YH, Gao QY, Cai GX, Sun XM, Sun XM, Zou TH, Chen HM, Yu SY, Qiu YW, Gu WQ, Chen XY, Cui Y, Sun D, Liu ZJ, Cai SJ, Xu J, Chen YX, Fang JY. Xie YH, et al. EBioMedicine. 2017 Nov;25:32-40. doi: 10.1016/j.ebiom.2017.10.005. Epub 2017 Oct 4. EBioMedicine. 2017. PMID: 29033369 Free PMC article. Clinical Trial.

1. Feng Q., Liang S., Jia H. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 2015;6:6528. - PubMed
1. Haug U., Hundt S., Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am. J. Gastroenterol. 2010;105:682–690. - PubMed
1. Kostic A.D., Chun E., Robertson L. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–215. - PMC - PubMed
1. Ladabaum U., Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia. Gastroenterology. 2016;151 427–39.e6. - PubMed
1. Nakatsu G., Li X., Zhou H. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun. 2015;6:8727. - PMC - PubMed